EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
06.11.25
/
50%
€9.59
Target price
06.11.26
€33.89
Performance (%)
62.58%
Price
23.12.25
€15.32
Summary
This prediction is currently active. With a performance of 62.58% the BUY prediction by Royal_Bank_of_Canada is a big success. This prediction currently runs until 06.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | 8.269% | 8.269% |
| iShares Core DAX® | 0.650% | 3.212% |
| iShares Nasdaq 100 | 1.650% | 0.322% |
| iShares Nikkei 225® | 1.232% | 1.549% |
| iShares S&P 500 | 1.413% | 0.282% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (NASDAQ:EYPT) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $39.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.18
17.06.25
17.06.25
€24.24
17.06.26
17.06.26
90.69%
23.12.25
23.12.25
